Sudden cardiac death in children and adolescents (excluding Sudden Infant Death Syndrome)

Annals of Pediatric Cardiology

Volumn 3, Issue 2, 2010, Pages 107-112

  Gajewski, Kelly K ^a   Saul, J Philip ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Children; hypertrophic cardiomyopathy; long QT syndrome; sudden cardiac death

Indexed keywords

ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; BRUGADA SYNDROME; CARDIAC CHANNELOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; COMMOTIO CORDIS; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DISEASE; HEART RIGHT VENTRICLE DYSPLASIA; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; RESUSCITATION; RISK ASSESSMENT; SUDDEN DEATH;

EID: 78650650154     PISSN: 09742069     EISSN: 09745149     Source Type: Journal    
DOI: 10.4103/0974-2069.74035     Document Type: Article

References (53)

1. Botvinick EH, Dae MW, Krishnan R, Ewing S. Hypertrophic cardiomyopathy in the young: Another form of ischemic cardiomyopathy? J Am Coll Cardiol 1993;22:805-7.
2. Garson A Jr. Sudden death in the young. Hosp Pract (Off Ed) 1991;26:51-60.
3. Gow RM. Sudden cardiac death in the young. Can J Cardiol 1996;12:1157-60.
4. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996;334:1039-44.
5. Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol 1985;5:118B-21.
6. O'Connor FG, Kugler JP, Oriscello RG. Sudden death in young athletes: Screening for the needle in a haystack. Am Fam Physician 1998;57:2763-70.
7. Silka MJ. Sudden death due to cardiovascular disease during childhood. Pediatr Ann 1991;20:360-7.
8. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profles. JAMA 1996;276:199-204.
9. Keren G. Etiology of sudden death in healthy active subjects. Isr J Med Sci 1989;25:607-9.
10. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9.
11. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-6.
12. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008;5:158-68.
13. Bahl OP, Massie E. Electrocardiographic and vectorcardiographic patterns in cardiomyopathy. Cardiovasc Clin 1972;4:95-112.
14. Ackerman MJ. Genetic testing for risk stratifcation in hypertrophic cardiomyopathy and long QT syndrome: Fact or fction? Curr Opin Cardiol 2005;20:175-81.
15. Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109:2807-16.
16. Mitten MJ, Maron BJ, Zipes DP. Task Force 12: Legal aspects of the 36th Bethesda Conference recommendations. J Am Coll Cardiol 2005;45:1373-5.
17. Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006;354:209-10.
18. Liberthson RR, Dinsmore RE, Fallon JT. Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management. Circulation 1979;59:748-54.
19. Vetter VL. Sudden death in infants, children, and adolescents. Cardiovasc Clin 1985;15:301-13.
20. Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 1986;256:2696-9.
21. Corrado D, Thiene G, Cocco P, Frescura C. Non-atherosclerotic coronary artery disease and sudden death in the young. Br Heart J 1992;68:601-7.
22. Nakamura CT, Canete DR, Lau JM. A review of the anomalous origin of the left coronary artery from the anterior sinus of Valsalva: Is prevention possible? Hawaii Med J 1993;52: 294-9.
23. Lipsett J, Cohle SD, Berry PJ, Russell G, Byard RW. Anomalous coronary arteries: A multicenter pediatric autopsy study. Pediatr Pathol 1994;14:287-300.
24. Taylor AJ, Byers JP, Cheitlin MD, Virmani R. Anomalous right or left coronary artery from the contralateral coronary sinus: «High-risk» abnormalities in the initial coronary artery course and heterogeneous clinical outcomes. Am Heart J 1997;133:428-35.
25. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation 1980;62:218-29.
26. Chadow H, Kwan T, Huber M, Feit A. Anomalous origin of the right coronary artery above the left posterior sinus of Valsalva associated with a normal aortic valve. A case history. Angiology 1994;45:963-6.
27. Ghosh PK, Agarwal SK, Kumar R, Chandra N, Puri VK. Anomalous origin of right coronary artery from left aortic sinus. J Cardiovasc Surg 1994;35:65-70.
28. Rinaldi RG, Carballido J, Giles R, Del Toro E, Porro R. Right coronary artery with anomalous origin and slit ostium. Ann Thorac Surg 1994;58:829-32.
29. Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: Proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:516-24.
30. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualifcation of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008;52:1990-6.
31. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009;120:1761-7.
32. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. New Engl J Med 1992;327:846-52.
33. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993;88:782-4.
34. Tester DJ, Ackerman MJ. Genetic testing for cardiac channelopathies: Ten questions regarding clinical considerations for heart rhythm allied professionals. Heart Rhythm 2005;2:675-7.
35. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005;2:507-17.
36. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specifc triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
37. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defbrillator and what happens to them?: Data from the European Long-QT Syndrome Implantable Cardioverter-Defbrillator (LQTS ICD) Registry. Circulation 2010;122:1272-82.
38. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.
39. Tester DJ, Arya P, Will M, Haglund CM, Farley AL, Makielski JC, et al. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. Heart Rhythm 2006;3:800-5.
40. Vincent GM. The Long QT and Brugada syndromes: Causes of unexpected syncope and sudden cardiac death in children and young adults. Semin Pediatr Neurol 2005;12:15-24.
41. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: An update. Heart 2009;95: 766-73.
42. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/ cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007;115:1710-20.
43. Sen-Chowdhry S, Syrris P, McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007;50:1813-21.
44. Sen-Chowdhry S, Prasad SK, Syrris P, Wage R, Ward D, Merrifeld R, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: Comparison with task force criteria and genotype. J Am Coll Cardiol 2006;48:2132-40.
45. rd, Link MS. Clinical profle and spectrum of commotio cordis. JAMA 2002;287:1142-6.
46. rd. Clinical profle of commotio cordis: An under appreciated cause of sudden death in the young during sports and other activities. J Cardiovasc Electrophysiol 1999;10:114-20.
47. Link MS, Wang PJ, Pandian NG, Bharati S, Udelson JE, Lee MY, et al. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med 1998;338:1805-11.
48. rd, Link MS. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics 2006;117:e656-62.
49. rd, Link MS, Maron BJ. Evaluation of chest barriers for protection against sudden death due to commotio cordis. Am J Cardiol 2007;99:857-9.
50. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998;32:245-51.
51. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-6.
52. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.
53. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-92.